Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanoPac Focal Therapy for Localized Prostate Cancer
NCT04221828Phase 2Terminated
- Sponsor
- NanOlogy
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NanoPac in prostate cancer (PCa), sponsored by NanOlogy. Started Oct 2020; status: terminated.
02
Drugs
NanoPac
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04221828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04221828.